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Abstract—Introduction: Hyperglycemia commonly 
occurs in critically ill patients due to metabolic 
stress. Hyperglycemia can cause gastric motility 
disturbance in which can cause high gastric residual 
volume (GRV). The objective of this study is to 
determine the relationship between hyperglycemia 
and high GRV status in ICU patients. 
Methods: This study used cross sectional method 
with consecutive sampling of 96 adult ICU patients. 
Blood glucose level were measured every 12 hours 
and GRV every 4 hours on first and second day 
admission to ICU. Data were analyzed with 
Statistical Package for Social Science Program 
(SPSS) version 20.0. The relationship between 
hyperglycemia status and high GRV status were 
analyzed using Chi-Square test. 
Results: Hyperglycemia status was found in 45.8% 
subjects on day 1 and 35.4% on day 2. High GRV 
status was found in 28.1% on day 1 and 25% on day 
2. There was no significant relationship between 
hyperglycemia and high GRV status on day 1 and 2 
(p=0.34 and 0.81).  However, in 12 subjects, we 
found high GRV occurred 19.67 ± 11.06 hours after 
the onset of hyperglycemia. 
Conclusion: There was no significant relationship 
between hyperglycemia status and high GRV status, 
but high GRV could be found later after 
hyperglycemia. 
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INTRODUCTION 
Hyperglycemia commonly occurs in critically ill 
patients due to metabolic stress, even though without 
history of diabetes.1–3 The prevalence of 
hyperglycemia varies in many researches. Van den 
Berghe et al4 found 12% of critically ill patients had 
blood glucose level >200 mg/dL. Another study by 
Cely et al5 found 38% of critically ill patients had 
blood glucose level >150 mg/dL and 23% of them 
had  >200 mg/dL. Unfortunately, data about 
prevalence of hyperglycemia in critically ill patients 
has not been found in Indonesia yet. 
 Based on the Normoglycemia in Intensive 
Care Evaluation-Survival Using Glucose Algorithm 
Regulation (NICE-SUGAR), hyperglycemia in 
critically ill is defined by blood glucose level >180 
mg/dL.6 It occurs due to insulin resistance and the 
increase of gluconeogenesis in responds to 
inflammation.1,3 It can also occur due to excessive 
intake and corticosteroids therapy.1,7 
 Hyperglycemia may results in gastric 
motility disturbance which alter gastric emptying 
and, therefore, can cause high gastric residual 
volume.8,9 A study by Nguyen et al10 shows high 
gastric residual volume occurred more often in 
patients who had hyperglycemia. The cut off points 
of high gastric residual volume varies from >150 mL 
to >500 mL.11–13 In Intensive Care Unit of Cipto 
Mangunkusumo Hospital, the cut off point used is 
>125 mL every 4 hours. 
 Prevalence of high gastric residual volume 
varies from 32‒60%.13,14 A study by Junizar15 in 
Cipto Mangunkusumo Hospital ICU found 23.3% of 
critically ill patients had high gastric residual 
volume. This condition can hinder adequate enteral 
feeding14 and increase the risk of aspiration16 which 
results in increase of mortality.17,18 Other causes of 
high gastric residual volume are low perfusion,19 
sympathetic response during metabolic stress,20 low 
potassium level,9 opioids and cathecolamine 
therapies.14,21 
 There are only few studies regarding the 
relationship between hyperglycemia in critically ill 
patients and high gastric residual volume. However, 
there is still no research data regarding this issue in 
Indonesia. Therefore, this study was conducted in 
ICU of Cipto Mangunkusumo General Hospital, 
Jakarta, Indonesia. The results of this study was 
expected to be able to estimate the percentage of 
hyperglycemia and high gastric residual volume for 
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additional knowledge in nutrition therapy for 
critically ill patients, especially in Indonesia. 
 
METHODS 
The study was done in May to August 2014 in Cipto 
Mangunkusumo General Hospital, Jakarta, 
Indonesia, and had been approved by the Ethics 
Committee of the Faculty of Medicine, University of 
Indonesia. The inclusion criteria were male and 
female, age 18‒59 years old, had nasogastric or 
orogastric enteral tube applied, and consented by 
their family or relatives to participate in this study. 
Any patient who had surgical procedure involving 
removal of pyloric sphincter was excluded.  
Data were collected within the first and 
second 24 hours of admission in ICU. Subjects who 
had earlier enteral tubes removal, left ICU (move to 
ward) or passed away before data collection was 
completed were dropped out from this study. The 
data was collected in the first and second 24 hours of 
admission in ICU to avoid large number of drop outs, 
loss to follow up, and too much data variation 
because the staying time differs greatly in this ICU. 
 The sample size was determined with the formula 
below and subject was recruited consecutively. 
According to formula below, minimum number of 
subject should be recruited was 96 patients. 
 
n = number of subject 
Zα = cut off point for statistical significance = 1.96, 
       for α= 0.05 
P = percentage of high gastric residual volume in 
critically ill patient with hyperglycemia. P was 
assumed to be 50% = 0.522  
Q = 1 – P  
d = acceptable drop out rate in clinical research = 10% 
 
The data collected were age, gender, weight, BMI, 
nutritional status, calorie intake, diagnosis, serum 
potassium level, MAP status, use of opioids and 
catecholamines from ICU medical charts. Blood 
glucose levels were measured by glucometer every 
12 hours starting from admission until 48 hours 
during ICU stay. Gastric residual volume was 
measured every 4 hours (gastric residue was 
collected in an empty container and its volume was 
measured). All parameters measured were divided 
into two categories: hyperglycemia (if there was at 
least once blood glucose level >180 mg/dL) and 
euglycemia (if blood glucose levels were ≤180 
mg/dL); high gastric residual volume (if there was at 
least once gastric residual volume >125 mL found) 
and normal (if gastric residual volume was ≤125 mL 
in each measurement); hypokalemia (serum 
potassium level was <3.5 mmol/L measured during 
this study) and normo/hyperkalemia (serum 
potassium levels were normal or >5.5 mmol/L);  low 
MAP status (if there was at least once MAP level <65 
mmHg) and normal MAP status (if MAP levels were 
≥65 mmHg); “yes” (if any opioid medication or 
catecholamine was used) and “no” (if it was not 
used).  
 Data were analyzed using Statistical 
Package for Social Science (SPSS) version 20.0. The 
Kolmogorov-Smirnov test of normality was used for 
age, weight, BMI, and calorie intake. Numerical data 
that are normally distributed will be shown in mean 
± standard deviation (SD); and in median 
(minimum–maximum value) if otherwise. 
Categorical data will be shown in distribution and 
frequency. The relationship between hyperglycemia 
and high gastric residual volume were analyzed 
using Chi-Square test. 
 
RESULTS 
Within 10 weeks of the study, 104 subjects were 
collected. There were 96 subjects analyzed. There 
were 8 subjects who were dropped out from this 
study: 2 subjects had their enteral tube removed and 
6 subjects passed away before 48 hours. 
Baseline characteristic of the subject are 
shown in Table 1 and 2. Percentage of 
hyperglycemia and high gastric residual volume 
status are shown in Figure 1. Analysis of relationship 
between hyperglycemia and high gastric residual 
volume of this study is shown in Table 3. There was 
no significant relationship between hyperglycemia 
status and high gastric residual volume in the first 
and second 24 hours of admission.  
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Additional analysis was done to determine the 
possibility of time needed to develop into high 
gastric residual volume from the time hyperglycemia 
was detected. There are 12 subjects who had high 
gastric residual volume after hyperglycemia was 
detected. The analysis showed the mean time 
measured was 19.67 ± 11.06 hours. 
DISCUSSION 
According to several studies, age,23,24 gender,25 
BMI,26 and calorie intake27,28 may affect blood 
glucose level or gastric residual volume. However in 
this study, none of those characteristics affected 
blood glucose level or gastric residual volume (data 
not shown). Calorie intakes were still below target 
recommended by ESPEN guidelines.29 Almost all 
subjects (98.96%) of this study received intermittent 
enteral feeding with slow drips. The nutrition 
composition given was a standard formula complied 
to ESPEN guidelines.30 Therefore, calorie intakes 
were considered not affecting the outcomes of this 
study. Other factors (potassium level, the use of 
opioid, and catecholamine medications) also did not 
affect gastric residual volume in this study (data not 
shown).  
 
Blood Glucose Level dan Gastric Residual 
Volume Status 
There was a significant decrease of hyperglycemia 
percentage (>10%) in second day of admission in 
ICU compared to first day. This could mean that 
hyperglycemia was promptly managed. In this ICU, 
management of hyperglycemia is done with strict 
glucose control by insulin starting from blood 
glucose >180 mg/dL. This cut off point is based on 
ASPEN Clinical Guidelines.31   
The proportion of hyperglycemia in this 
study is lower compared to other studies by Van den 
Berghe et al4 (12%) and Cely et al5 (38%). This can 
be due to higher blood glucose cut-off point in both 
studies (>200 mg/dL). 
There was no significant decrease of subjects 
with high gastric residual volume status in this study. 
This number also does not differ significantly 
compared to study by Junizar et al15 (23.3%). The 
number of subjects with high gastric residual volume 
in this study is lower compared to studies by Mentec 
World Nutrition Journal vol.1 No. 1 July 2017 | http://dx.doi.org/10.25220/WNJ.V01i1.0003 
 
10 
et al14 (32%) and Metheny et al16 (72.8%) which can 
be due to different cut-off point and frequency of 
measurement used in both studies.  
 
The relationship between hyperglycemia and high 
gastric residual volume 
The results showed no significant relationship 
between hyperglycemia and high gastric residual 
volume in both first and second 24 hours of 
admission in ICU. These results were similar with a 
study by Mentec et al14 which found no significant 
difference of blood glucose level between subjects 
with high and normal gastric residual volume. The 
result of this study differs from a study by Nguyen et 
al10 which found high gastric residual volume was 
associated with hyperglycemia. The difference of the 
results may due to difference in the studies objectives 
and blood glucose measurement frequencies. 
Additional analysis was done to determine 
the possibility of time needed to develop into high 
gastric residual volume from the time hyperglycemia 
was detected. The analysis of 12 subjects with high 
gastric residual volume occurred after 
hyperglycemia showed the mean time measured was 
19.67 ± 11.06 hours. A study by Nguyen et al10 
showed critically ill patients who are intolerant of 
enteral feeding had a trend for higher blood glucose 
levels on admission and had greater variation in 
blood glucose levels, especially 24 hours prior to 
enteral feeding intolerance. However, in this 
research, the analysis can not be concluded due to 
lack of numbers of subject. Therefore, further 
research with case control or longitudinal method is 
needed to determine this issue.  
 No relationship between hyperglycemia and 
high gastric residual volume in this study could be 
due to the length of study time, blood glucose level 
measurement frequencies and management of 
hyperglycemia in subjects. Longer time is probably 
needed to observe the effect of hyperglycemia to 
gastric residual volume. In this study, blood glucose 
level measurements done other than every 12 hours 
were not included in the analysis. Therefore, there 
were possibly more subjects who had 
hyperglycemia. In addition, the prompt management 
of hyperglycemia in this study possibly hindered the 
high gastric residual volume to develop. For those 
reasons, further research using case control or 
longitudinal method is needed. Using more frequent 
blood glucose level measurements or continuous 
blood glucose monitoring is suggested in further 
research. 
 There are limitations to this study. This 
study did not examine disease severity and more 
specific diagnosis of the subjects in which would 
possibly affect gastric emptying rate. Data were only 
collected within two days, therefore it may be too 
short to observe the effect of hyperglycemia to 
gastric residual volume. Blood glucose level was 
measured every 12 hours, therefore any 
hyperglycemia occurred beyond those time could be 
missed. The design of this study could also become 
a limitation. We used cross sectional study, whose 
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data was divided categorically, to determine the 
relationship because high gastric residual volume 
was expected to happen concurrently with 
hyperglycemia onset or after hyperglycemia 
occurred. Diabetic patients were not excluded, which 
could also affect the outcome of this study. Gastric 
emptying disorder frequently occurs in patients with 
chronic diabetes mellitus. 
In conclusion, there was no significant 
relationship between hyperglycemia status and high 
gastric residual status in this study. Further research 
with more frequencies of blood glucose 
measurements or using continuous blood glucose 
monitoring is needed to better determine the 
hyperglycemia status in critically ill patients. Further 
research is also needed to determine whether 
episodic or chronic hyperglycemia can cause high 
gastric residual volume much later, and also 
observation on the average time from the beginning 
of hyperglycemia to develop into high gastric 
residual volume is needed. 
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